Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
Title/Summary: Tender for the procurement of substitute medications for the Health Development Institute issued by the State Support Services Center in Tallinn, Estonia. Submission deadline is December 11, 2026.
Scope Of Work: The tender involves the supply of two main pharmaceutical products: Part I includes 12,000 liters of methadone hydrochloride (1 mg/ml) oral solution in 1,000 ml packaging or an equivalent volume. Part II covers 7,000 tablets of a combination medication containing 8 mg of buprenorphine and 2 mg of naloxone, which must be divisible into equal doses. Orders will be based on actual needs, with a delivery timeframe of no more than two working days from order receipt. The minimum shelf life at the time of delivery must be at least 12 months.
Qualification Criterion: Bidders must meet specific qualification criteria as outlined in the tender documents, including compliance with pharmaceutical standards and the ability to deliver the required quantities within the specified time frame. Relevant experience in supplying similar medications and adherence to packaging requirements are essential. Mandatory submissions include technical specifications and proof of compliance with regulatory standards.
Purchaser contact is for registered users
Login to see detailsTender details are for registered users
Login to see details| Tender | Country | TOT Ref. No. | Bid deadline |
|---|---|---|---|
| Purchase of Vaccines Re-Procurement | Estonia | 152609905 | 14 Dec 2026 |
| N01ax10 Propofol | Estonia | 152609695 | 02 Dec 2026 |
| Diapers and Mesh Pants for Overweight Patients | Estonia | 152609685 | 02 Dec 2026 |
| Purchase of Single-Use Rapid Tests for the Detection of Narcotic and Psychotropic Substances for Prisons | Estonia | 152609658 | 03 Dec 2026 |
| Accessories Necessary for the Administration of Radionuclide Therapy (Shielded System) _Ii | Estonia | 152609643 | 01 Dec 2026 |